Ratings Harte Hanks, Inc.

Equities

HHS

US4161962026

Market Closed - Nasdaq 01:30:00 2024-07-03 pm EDT 5-day change 1st Jan Change
8.79 USD +1.62% Intraday chart for Harte Hanks, Inc. +10.71% +29.46%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Its low valuation, with P/E ratio at 11.42 and 6.35 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company shows low valuation levels, with an enterprise value at 0.22 times its sales.
  • Sales forecast by analysts have been recently revised upwards.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company sustains low margins.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Advertising & Marketing

1st Jan change Capi. Investor Rating ESG Refinitiv
+29.46% 63.65M -
+3.62% 2.29B
B-
-32.55% 459M - -
+32.42% 427M - -
-28.67% 367M - -
-4.31% 137M
C
-49.23% 116M - -
+3.74% 109M - -
+72.17% 90.94M -
+6.73% 85.85M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. HHS Stock
  4. Ratings Harte Hanks, Inc.